1. Home
  2. FLNT vs VRCA Comparison

FLNT vs VRCA Comparison

Compare FLNT & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$3.03

Market Cap

96.1M

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$4.91

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNT
VRCA
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
88.0M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
FLNT
VRCA
Price
$3.03
$4.91
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$3.50
$17.00
AVG Volume (30 Days)
32.3K
101.8K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
41.67
N/A
EPS
N/A
N/A
Revenue
$208,764,000.00
$35,577,000.00
Revenue This Year
$5.89
N/A
Revenue Next Year
$12.62
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$1.70
$3.28
52 Week High
$4.49
$9.82

Technical Indicators

Market Signals
Indicator
FLNT
VRCA
Relative Strength Index (RSI) 30.66 43.32
Support Level $2.95 $4.52
Resistance Level $3.05 $5.94
Average True Range (ATR) 0.21 0.40
MACD -0.10 0.01
Stochastic Oscillator 8.52 27.20

Price Performance

Historical Comparison
FLNT
VRCA

About FLNT Fluent Inc.

Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: